
AI Health Week explores what’s next in medical innovation
News
Hosted by RAISE Health, the weeklong event tackled ethical AI, pediatric advancements, and how clinicians and researchers can thrive alongside emerging technologies.

Creation of vascularized mini-organs marks milestone in regenerative medicine
Research
Stanford researchers have created the first lab-grown heart and liver organoids with their own blood vessels, paving the way for new regenerative therapies.

AI lets clinicians ‘chat’ with medical records
News
Developed at Stanford Medicine, ChatEHR is expediting chart reviews and other tasks by allowing clinicians to ask questions of electronic health information.

Study links blood sugar reactions to personalized diabetes risk
Research
Stanford-led research shows that people respond differently to carbohydrates based on their metabolic profile, offering a path toward more tailored prevention and treatment strategies.

Study reveals how sensory experiences trigger lasting emotions
Research
Scientists found that humans and mice share persistent brain-activity patterns in response to negative sensory inputs – offering insight into emotion and potential links to neuropsychiatric disorders.

After the joy of birth, new moms face ‘the wilderness’ – Stanford is tracking what comes next
News
The Stanford Obstetric Recovery Checklist, or STORK, measures the well-being of mothers after they leave the hospital.

Scientists track down mutation that makes orange cats orange
Research
It took researchers a century to find the genetic glitch that causes orange coloration in cats.

Inder Perkash, pioneer in spinal cord injury care, dies at 91
Obituary
Perkash pioneered treatment of urologic issues in veterans with spinal cord injuries.

Five things to know about measles risks and vaccine safety
News
Stanford pediatrics professor Bonnie Maldonado draws on 15 years of research to clarify key facts about measles outbreaks, vaccine effectiveness, and who’s most at risk.

Study links CAR-T cell cancer therapy to ‘brain fog’
News
Stanford Medicine researchers found the treatment can cause mild cognitive impairment – and identified compounds that may help reverse it.